London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
24.5p are buys!
1MM@24.75p
1MM@25p
4MM@25.5p
2MM@26p
This is a really positive move. We tested the 200 DMA twice and are now moving up. Also its good to see few sells as we move up. Then we are also getting decent buys. All is looking very positive.
I haven't bought more today, but if there's another one of these RNS's, then we're about right MCap wise (two "potential" assets, which have already undergone some fairly rigorous analysis/due dil). If it's sub 25p, it would be a no brainer for me to top up again.
The above is irrespective of the 3 legacy assets, 2 of which already have clinical data. As the yanks say, go figure.
Rb -be good if it was fingers crossed. Well await tr1 :o)
Be aware sell and buy price now the same . . .
L2 getting sexy
Obviously this is a long game, i cant deny i'm hoping this breaks out big style, i could do with a break frankly having a **** time but its a fairly thinly traded stock, so you never know, not easy to buy chucks so it can move quickly if the buyers are there.....
Good Luck all anyhow
Pork's
Its got to be an Insto buying all these 50k must be.
Looks like they've putit right now, 23.70 is a sell hmmm interesting day then folks
Ice I agree also think the 50k share buy at 24 followed by 3x50k at 23.65 are also buys as the sell price at exactly that time had changed to 23.50 . . ..
So rhurb you loading up again ;o) lol
23.5p are all buys. DO a dummy trade!
Today's target revised! 26p to 27p!
Level 2:
5MM @24p
1MM @24.25p
2MM@25p
23.53p to sell
25.50p to buy
MM back to playing games. All buys showing up as sell. But if investors keep buying MM will have to let this go!
Its a tough one because well this is the AIM and anther stock im in that i consider under its fundamental value keeps getting a royal kicking, so sentiment plays a massive part.
With Valirx Suzy has a number of great products in the offering on the brink of licensing deals. From a sentimental point of view who doesn't want to back a business trying to make a difference with Cancer? Todays deal on Breast Cancer another area we desperately need solutions for hence; market perception with the right coverage should bode well
Then the biggie for me, company value at £15m, now we all know that just one licensing deal will absolutely blow this away this could be a 10-20 bagger return from here all day long so, is it worth buying a few and locking them away heck it sure is.
Anyhow, good luck what ever your call, see what she has to say shortly
GLA
For me this RNS makes it clear that their new strategy is now in place. Whilst Valirx as a body of scientists and experts are now focusing primarily on evaluating new technologies/innovations and progressing drug development stages of their existing portfolio. I believe Cenkos have now been appointed to become the commercial arm of the business, looking to create suitable partnering deals and market products in a way that will rally interest.
No…it doesn’t mean that a partnering deal is necessarily imminent (PM I’m looking at you here!). What it shows is that they’re getting on with business in the right way, with experts in their fields, sat where they need to be.
How's L2 looking?
Suzy pushing news through before the meeting. Could well get the big 201 deal that is due in the next few days.
No doubt will have lots to talk about if the deal comes and new pipeline.
Looking forward to the Investor Presentation and Q&A
I have EVERY confidence in Suzy
Hence why i have increased my position here
Let's see if it will be that "transformative" year.....
Wow GL
Deal worked in
650,000 @ 24.5
Good Luck Guys......
you never know...